1. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI).

Panduan
Praktik Klinis. Perdoski. 2017;150
2. Kelly Y, Blanco A, Tosti A. Androgenetic Alopecia: An Update of Treatment Options.
Springer Int. Publ. Switz. 2016; 76(14): 1349–64.
3. Ho CH, Sood T, Zito PM. Androgenetic Alopecia. Men’s Heal 3ed. 2020;352–67.
4. Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic Alopecia: An update. Indian J
Dermatol Venereol Leprol. 2013;79(5): 613–25.
5. Umborowati MA, Rahmadewi. Rambut Rontok Akibat Lingkungan dan Kosmetik
(Environment and Cosmetic Induced Hair Loss ). J Univ Airlangga. 2012; 24( 318):35–42.
6. Kabir Y, Goh C. Androgenetic Alopecia: update on epidemiology, pathophysiology, and
treatment. J Egypt Womenʼs Dermatologic Soc. 2013;10(3): 107–16.
7. Legiawati L. Alopesia Androgenetik. Mdvi. 2013; 40(2): 96–101
8. Stephanie A.Tata Laksana. Contin. Prof. Dev. 2018; 45(8): 582–87
9. Li R, Brockschmidt FF, Kiefer AK, Stefansson H, Nyholt DR, Song K, et al. Six novel
susceptibility loci for early-onset androgenetic alopecia and their unexpected association
with common diseases. PLoS Genet. 2012;8(5): 1–9
10. Sonthalia S, Daulatabad D, Tosti A. Hair Restoration in Androgenetic Alopecia: Looking
Beyond Minoxidil, Finasteride and Hair Transplantation. J. Cosmetol. Trichology.
2016;02(01):1-13
11. Tsuboi R, Itami S, Inui S, Ueki R, Katsuoki K, Kurata S, et al. Guidelines for the
management of androgenetic alopecia. J. Dermatol. 2012; 39(2):113–20.
12. Inui S, Itami S. Molecular basis of androgenetic alopecia: From androgen to paracrine
mediators through dermal papilla. J. Dermatol. Sci. 2011; 61(1): 1–6
13. Heilmann S, Kiefer AK, Fricker N, Drichel D, Hillmer AM, Herold C, et al. Androgenetic
alopecia: Identification of four genetic risk loci and evidence for the contribution of WNT
signaling to its etiology. J. Invest. Dermatol. 2013;133(6): 1489–96.
14. Heimbach SH, Herold C, Hochfeld LM, Hillmer AM, Nyholt DR, Hecker J, et al.
Metaanalysis identifies novel risk loci and yields systematic insights into the biology of
male-pattern baldness. Nat. Commun. 2017; 8(1):1–8.
15. Gan DC, Sinclair R. Androgenetic Alopecia. Men’s Heal Third Ed. 2014;8: 314–24
16. Trueb RM, Tobin DJ. Aging hair. Springer. 2010;1–270p
17. Werner B, Brenner FM. Clinical and histological challenge in the differential diagnosis of
diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata part
II. An. Bras. Dermatol. 2012; 87(6): 884–90.
18. Ji Q, Garza LA. An overview of alopecias. Cold Spring Harb. Perspect. Med. 2014;
4(3):1–14
19. Yu NL, Tan H, Song ZQ, Yang XC. Illness perception in patients with androgenetic
alopecia and alopecia areata in China. J. Psychosom. Res. 2016; 86(1): 1–6.
20. Lucky AW, Piacquadio DJ, Ditrie CM, Dunlap F, Kantor I, Pandya AG, et al. A
randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the
treatment of female pattern hair loss. J. Am. Acad. Dermatol. 2004; 50(4):541–53.
21. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JA,Tschen EH, et al. A
 randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo
in the treatment of androgenetic alopecia in men. J. Am. Acad. Dermatol. 2014; 47(3):77–
85.
22. Meidan VM, Touitou E. Treatments for androgenetic alopecia and alopecia areata: Current
options and future prospects. Adis Int. Ltd. 2011; 61(1): 53–69.
23. Alsantali A. Alopecia areata: a new treatment plan. Clin. Cosmet. Investig. Dermatol.
2011; 4(1):107-15.doi:10.2147/ccid.s22767.
24. Hugo Perez BS. Ketocazole as an adjunct to finasteride in the treatment of androgenetic
alopecia in men. Med. Hypotheses. 2014;62(1): 112–15.
25. Tosti, A. Hair and nail disorders. Introduction. Semin. Cutan. Med. Surg. 28, 1–2 (2019).
26. Avci, P., Gupta, G. K., Clark, J., Wikonkal, N. & Hamblin, M. R. Low-level laser (light)
therapy (LLLT) for treatment of hair loss. Lasers Surg. Med. 46, 144–151 (2014).
27. Egger, A. et al. Examining the Safety and Efficacy of Low-Level Laser Therapy for Male
and Female Pattern Hair Loss: A Review of the Literature. Ski. Appendage Disord. 6, 259–
267 (2020).
28. Satino, J. L. & Markou, M. Hair regrowth and increased hair tensile strength using the
HairMax LaserComb for low-level laser therapy. Int. J. Cosmet. Surg. Aesthetic
Dermatology 5, 113–117 (2003).
29. Dinh, Q. Q. & Sinclair, R. Female pattern hair loss: current treatment concepts. Clin.
Interv. Aging 2, 189–199 (2017).
30. Yeon, J. H. et al. 5 mg/day finasteride treatment for normoandrogenic Asian women with
female pattern hair loss. J. Eur. Acad. Dermatology Venereol. 25, 211–214 (2019).
31. Tanaka, Y., Aso, T., Ono, J., Hosoi, R. & Kaneko, T. Androgenetic alopecia treatment in
Asian men. J. Clin. Aesthet. Dermatol. 11, 32–35 (2018).
32. Jang, Y. H. et al. Long-Term Prognosis of Alopecia Totalis and Alopecia Universalis: A
Longitudinal Study with More than 10 Years of Follow-Up: Better than Reported.
Dermatology 233, 250–256 (2017).